Cyclica (acquired by Recursion, Nasdaq: RXRX)’s Post

Marketing highly-technical, scientific material is a tricky business. See how Cyclica leaned into #MaRSMomentum's Marketing Mastermind series to develop a clear and compelling storytelling strategy.

Recursion announced an incredible achievement today. Using NVIDIA’s DGX Cloud and our own NVIDIA-based supercomputer, BioHive-1, Recursion bridged the protein and chemical space by predicting the protein target(s) for ~36 billion compounds in the Enamine Ltd. REAL Space. I am personally so excited about this. 🚀 💊 For many years at Cyclica we aspired to achieve this large scale match of the chemical universe to the protein universe. In fact, at Cyclica our mission was to “Open new frontiers in drug discovery by matching the chemical universe to the entire protein universe”. I’m so glad to see this come to reality - one of many examples underpinning the strength of the strategic partnership between Recursion and Cyclica.  And we're only getting started. Kudos to Chris Gibson, Ben Mabey, Imran Haque, Stephen MacKinnon and everyone involved in this project - what a giant leap forward. Learn more: https://lnkd.in/gaBFrCat This announcement follows a number of exciting developments across our technology, pipeline and partnerships over the past several months, which we reported today in our Q2 business updates and financial results. Learn more: https://lnkd.in/gF8uWrtv #biotech #drugdiscovery #machinelearning #artificialintelligence #alphafold #chemistry #polypharmacology

Today, we begin our new journey as Valence Labs: a semi-autonomous research engine within Recursion, dedicated to advancing the frontier of deep learning in drug discovery. We’ve got a lot in store. Read on to learn more ⬇️ We are committing up to $1 million to advance the next generation of academic machine learning research and talent through scholarships, fellowships and other talent programs. Learn more about the Valence Scholars program & apply now: https://lnkd.in/eHxRy5zk This is just the beginning. Combining the intellectual freedom of academia with the resources and stability of industry, Valence Labs will take a long-term view on technology development, working at the frontiers of #machinelearning and therapeutic discovery. As we build, we will remain steadfast in our commitment to open-source and open-science. Stay tuned for the release of data, tools and infrastructure in the near future! There is challenging and exciting work to be done, and we hope that you feel inspired to join us in writing this next chapter. Read the full story: https://lnkd.in/evSw8J24 #techbio #artificialintelligence #deeplearning #digitalchemistry #ML #icml2023